Revolutionizing Healthcare: Microbot Medical Speeds Up Patient Enrollment for Groundbreaking Clinical Trial, Exceeding Expectations with 80% of Participants Already Completing Follow-Up
Revolutionizing Healthcare: Microbot Medical Speeds Up Patient Enrollment for Groundbreaking Clinical Trial Exceeding Expectations with 80% of Participants Already Completing Follow-Up Confirms the Company on Track for FDA 510(k) Submission by end of 2024 Completes All IDE required Tests and Receives Final IDE Approval from the FDA for the ACCESS-PVI Study BRAINTREE, Mass., Sept. 30,…